Eunkeu Oh

Title: Eunkeu Oh: Innovator in Gold Nanoparticle-Based Peptide Chip Technology

Introduction

Eunkeu Oh is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative tools for enzyme activity analysis. His work has implications for disease diagnosis and drug development.

Latest Patents

Eunkeu Oh holds a patent for the "Construction of gold nanoparticle-based peptide chip, and assaying enzyme activity and inhibitor effect using secondary ion mass spectrometric analysis thereof." This invention involves a gold nanoparticle (AuNP)-based peptide chip that is prepared by forming a monolayer of AuNPs onto a self-assembled monolayer constructed on a solid support. A peptide is then immobilized on the AuNPs, which effectively amplifies the mass signal of the peptide. This technology allows for the simple and accurate measurement of mass changes in peptides. Furthermore, when secondary ion mass spectrometric analysis is performed on the AuNP-based peptide chip, it enables the effective quantification of enzyme activities and related inhibitors. This invention provides a rapid and accurate method for analyzing various enzyme activities, which is crucial for understanding signaling and interaction mechanisms in disease diagnosis and new drug development.

Career Highlights

Eunkeu Oh has worked at notable institutions such as the Korea Advanced Institute of Science and Technology and the Korea Research Institute of Standards and Science. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.

Collaborations

Eunkeu Oh has collaborated with esteemed colleagues, including Hak-Sung Kim and Young-Pil Kim. Their joint efforts have further advanced research in the area of peptide chip technology.

Conclusion

Eunkeu Oh's innovative work in gold nanoparticle-based peptide chip technology represents a significant advancement in the field of biotechnology. His contributions have the potential to enhance disease diagnosis and facilitate new drug development.